279 related articles for article (PubMed ID: 20585746)
1. [Biologics. New drugs, new adverse reactions].
Prinz JC
Hautarzt; 2010 Aug; 61(8):668-75. PubMed ID: 20585746
[TBL] [Abstract][Full Text] [Related]
2. New biologics for psoriasis and psoriatic arthritis.
Rozenblit M; Lebwohl M
Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
[TBL] [Abstract][Full Text] [Related]
3. Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
Vu TT; Gooderham M; Papp K
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1423-1433. PubMed ID: 27690669
[TBL] [Abstract][Full Text] [Related]
4. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
5. Safety of biologics in psoriasis.
Kamata M; Tada Y
J Dermatol; 2018 Mar; 45(3):279-286. PubMed ID: 29226369
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
7. New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection.
Ceccarelli M; Venanzi Rullo E; Berretta M; Cacopardo B; Pellicanò GF; Nunnari G; Guarneri C
Dermatol Ther; 2021 Jan; 34(1):e14660. PubMed ID: 33301216
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
Kamata M; Tada Y
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121574
[TBL] [Abstract][Full Text] [Related]
9. Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents.
Weger W
Br J Pharmacol; 2010 Jun; 160(4):810-20. PubMed ID: 20590580
[TBL] [Abstract][Full Text] [Related]
10. Secukinumab for treating plaque psoriasis.
Rothstein B; Gottlieb A
Expert Opin Biol Ther; 2016; 16(1):119-28. PubMed ID: 26577956
[TBL] [Abstract][Full Text] [Related]
11. Use of biologic agents in pediatric psoriasis.
Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study.
De Simone C; Caldarola G; Maiorino A; Tassone F; Campana I; Sollena P; Peris K
Dermatol Ther; 2016 Sep; 29(5):372-376. PubMed ID: 27146358
[TBL] [Abstract][Full Text] [Related]
13. [Infliximab].
Herrera E; Habicheyn S
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
[TBL] [Abstract][Full Text] [Related]
14. Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis.
Henderson Berg MH; Carrasco D
J Drugs Dermatol; 2017 Jul; 16(7):695-698. PubMed ID: 28697222
[TBL] [Abstract][Full Text] [Related]
15. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
Al-Mutairi N; Nour T
Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
[TBL] [Abstract][Full Text] [Related]
16. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis.
Leman J; Burden AD
Br J Dermatol; 2012 Nov; 167 Suppl 3():12-20. PubMed ID: 23082811
[TBL] [Abstract][Full Text] [Related]
17. Pediatric psoriasis: updates in biologic therapies.
Sukhatme SV; Gottlieb AB
Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
[TBL] [Abstract][Full Text] [Related]
18. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.
Kurizky PS; Ferreira Cde C; Nogueira LS; Mota LM
An Bras Dermatol; 2015; 90(3):367-75. PubMed ID: 26131868
[TBL] [Abstract][Full Text] [Related]
19. Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region.
Al Hammadi A; Al-Sheikh A; Ammoury A; Ghosn S; Gisondi P; Hamadah I; Kibbi AG; Shirazy K
J Dermatolog Treat; 2017 Mar; 28(2):129-135. PubMed ID: 27196814
[TBL] [Abstract][Full Text] [Related]
20. Biologics for psoriasis: What is new?
Özyurt K; Ertaş R; Atasoy M
Dermatol Ther; 2019 May; 32(3):e12916. PubMed ID: 30972872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
